LGALS14 Antikörper (N-Term)
Kurzübersicht für LGALS14 Antikörper (N-Term) (ABIN2775472)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Sequenz
- MSSLPVPYTL PVSLPVGSCV IITGTPILTF VKDPQLEVNF YTGMDEDSDI
-
Homologie
- Human: 100%
-
Produktmerkmale
- This is a rabbit polyclonal antibody against LGALS14. It was validated on Western Blot using a cell lysate as a positive control.
-
Aufreinigung
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the N terminal region of human LGALS14
-
-
-
-
Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
-
Kommentare
-
Antigen size: 139 AA
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- LGALS14 (Lectin, Galactoside-Binding, Soluble, 14 (LGALS14))
-
Andere Bezeichnung
- LGALS14
-
Hintergrund
-
This gene is predominantly expressed in placenta. The encoded protein belongs to the galectin (galaptin/S-lectin) family. The members of galectin family contain one or two carbohydrate recognition domains, which can bind beta-galactoside. Two alternativel
Alias Symbols: CLC2, MGC22235, PPL13
Protein Interaction Partner: TRIM27, LNX1, BANP, ADAMTSL4, CRLF3, SDCBP2, FCHO1, IKZF3, MID2, SPAG5, TNR, TCF4, REL, GFAP, FLNA,
Protein Size: 139 -
Molekulargewicht
- 16 kDa
-
Gen-ID
- 56891
-
NCBI Accession
- NM_020129, NP_064514
-
UniProt
- Q8TCE9
Target
-